Related Experiment Video
Updated: Apr 27, 2026

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
Published on: September 14, 2013
Clostridium difficile infection in older adults
1Geriatric Research Education & Clinical Center & Infectious Diseases Section, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, 10701 East Blvd, Cleveland, OH 44106, USA ; Division of Infectious Diseases & HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Clostridium difficile infection disproportionately affects older adults, with age and antibiotic use as key risks. Prevention involves infection control and antibiotic stewardship.
Area of Science:
- Infectious Diseases
- Geriatrics
- Microbiology
Background:
- Clostridium difficile infection (CDI) is a leading cause of hospital-acquired diarrhea, particularly impacting the elderly.
- Key risk factors for CDI include prior antibiotic exposure and advanced age (over 65).
- Older adults face unique risks due to frequent healthcare system contact and age-related physiological changes like immune senescence and altered gut microbiota.
Purpose of the Study:
- To summarize the epidemiology, risk factors, and management strategies for Clostridium difficile infection in older adults.
- To highlight current and alternative therapeutic options for CDI.
- To outline essential preventive measures for CDI.
Main Methods:
- Literature review and synthesis of existing research on Clostridium difficile infection.
- Analysis of risk factors, treatment modalities, and prevention strategies.
- Focus on the specific challenges and considerations for the geriatric population.
Main Results:
- Antimicrobial exposure and age over 65 are primary risk factors for CDI.
- Standard treatments include metronidazole and oral vancomycin.
- Fidaxomicin and fecal bacteriotherapy represent effective alternative treatments.
Conclusions:
- Effective prevention of CDI in older adults necessitates robust infection control practices and judicious antimicrobial use.
- Understanding age-specific risk factors is crucial for targeted prevention and management strategies.
- Fecal bacteriotherapy shows promise as an alternative therapeutic approach for CDI.
Related Concept Videos
Development of Human Microbiota
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

